cyclo(Gly-O-Pro),
cyclo(Gly-Pro),
cyclo(glycyl-L-prolyl),
cyclo(glycylprolyl),
cyclo(glycylprolyl), (L)-isomer,
(S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione,
3705-27-9,
Cyclo(glycyl-L-prolyl),
(8aS)-octahydropyrrolo[1,2-a]piperazine-1,4-dione,
CYCLO-(GLYCINE-L-PROLINE) INHIBITOR,
(8AR)-HEXAHYDROPYRROLO[1,2-A]PYRAZINE-1,4-DIONE,
(8aS)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione,
Cyclo(gly-pro),
Cyclo-Gly-Pro,
GIO,
SMR000386902,
CYCLO(-GLY-PRO),
Cyclo-prolylglycine,
Cyclo(prolylglycyl),
Cyclo(pro-O-gly),
1,4-dioxo,
Cyclo(L-Pro-Gly-),
1w1p,
AC1L2PU5,
AC1Q1GU2,
MLS001049064,
MLS004714430,
CHEMBL360216,
SCHEMBL4247464,
OWOHLURDBZHNGG-YFKPBYRVSA-N,
HMS2270J17,
ZINC402826,
FCH838676,
MFCD00055967,
AKOS006273250,
DB04541,
MCULE-2043730253,
NCGC00246192-01,
AJ-21887,
AK-83285,
AS-34882,
EN001860,
ZB012963,
AB0180519,
AB1001030,
AX8173941,
DB-019155,
TC-306476,
CS-0053108,
FT-0773992,
ST24036292,
(8aS)-hexahydropyrrolo[1,2-a]piperazine-1,4-dione,
(S)-Hexahydropyrrolo(1,2-a)pyrazine-1,4-dione-4-17O,
Pyrrolo(1,2-a)pyrazine-1,4-dione-4-170, hexahydro-, (S)-,
Pyrrolo(1,2-a)pyrazine-1,4-dione-4-17O, hexahydro-, (S)-,
(8aS)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione,
97011-16-0,
null,
Cyclo(pro-gly),
Cyclo(glycylprolyl),
Cyclo(Gly-L-Pro),
CYCLO,
AR-1I2816,
CID126154,
ACN-026371,
(R)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione,
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-, L-,
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-, (S)-,
96193-26-9,
(S)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione, 95% - 1G 1g,
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-, (8aS)- (9CI),
406212-51-9,
4928-03-4,